DM
NAMS icon

Deerfield Management’s NewAmsterdam Pharma NAMS Stock Holding History

Deerfield Management’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137M Buy
4,264,789
+100,000
+2% +$3.26M 1.61% 20
2025
Q4 		$146M Sell
4,164,789
-101,904
-2% -$3.71M 1.87% 14
2025
Q3 		$121M Sell
4,266,693
-849,260
-17% -$20.4M 1.86% 12
2025
Q2 		$92.6M Buy
5,115,953
+1,011,996
+25% +$18.5M 1.68% 18
2025
Q1 		$84M Sell
4,103,957
-210,383
-5% -$4.68M 1.67% 19
2024
Q4 		$111M Buy
4,314,340
+3,412,590
+378% +$72.5M 2.11% 13
2024
Q3 		$15M Buy
901,750
+32,500
+4% +$562K 0.22% 59
2024
Q2 		$16.7M Buy
869,250
+202,250
+30% +$4.06M 0.28% 54
2024
Q1 		$15.8M Buy
+667,000
New +$13.5M 0.27% 60
2023
Q3 		– Sell
-2,535,723
Closed -$30.1M – 100
2023
Q2 		$30.1M Hold
2,535,723
– – 0.64% 38
2023
Q1 		$33.6M Buy
2,535,723
+55,524
+2% +$701K 0.75% 38
2022
Q4 		$27M Buy
+2,480,199
New +$24.7M 0.56% 51

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DFO
Duquesne Family Office New York $2.94B AUM 61.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return